Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised, Double-Blind, Parallel Group, Dose-Ranging, Placebo-Controlled, Multi-Centre, Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 (0.3, 1, 3, 10 mg) and Placebo on Stopping Preterm Labour and Uterine Contractions in Pregnant Women With Advanced Gestational Age.

Next Previous
Trial Profile

A Randomised, Double-Blind, Parallel Group, Dose-Ranging, Placebo-Controlled, Multi-Centre, Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 (0.3, 1, 3, 10 mg) and Placebo on Stopping Preterm Labour and Uterine Contractions in Pregnant Women With Advanced Gestational Age.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 21 May 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Barusiban (Primary)
  • Indications Preterm labour
  • Focus Therapeutic Use
  • Sponsors Ferring Pharmaceuticals

Most Recent Events

  • 01 Jun 2009 Results published in the American Journal of Obstetrics and Gynecology.
  • 20 May 2009 Actual end date changed from Jun 2006 to Aug 2006 as reported by ClinicalTrials.gov.
  • 20 May 2009 Actual patient number (163) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top